Literature DB >> 14675751

TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors.

Christi Gendron1, Masahide Kashiwagi, Clare Hughes, Bruce Caterson, Hideaki Nagase.   

Abstract

Aggrecanases are considered to play a key role in the destruction of articular cartilage during the progression of arthritis. Here we report that the N-terminal inhibitory domain of tissue inhibitor of metalloproteinases 3 (N-TIMP-3), but not TIMP-1 or TIMP-2, inhibits glycosaminoglycan release from bovine nasal and porcine articular cartilage explants stimulated with interleukin-1alpha or retinoic acid in a dose-dependent manner. This inhibition is due to the blocking of aggrecanase activity induced by the catabolic factors. Little apoptosis of primary porcine chondrocytes is observed at an effective concentration of N-TIMP-3. These results suggest that TIMP-3 may be a candidate agent for use against cartilage degradation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675751     DOI: 10.1016/s0014-5793(03)01295-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex.

Authors:  Linda Troeberg; Barbara Mulloy; Peter Ghosh; Meng-Huee Lee; Gillian Murphy; Hideaki Nagase
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

2.  Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis.

Authors:  Mandana Mahmoodi; Solmaz Sahebjam; David Smookler; Rama Khokha; John S Mort
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

3.  Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2.

Authors:  W Hui; H E Barksby; D A Young; T E Cawston; N McKie; A D Rowan
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

4.  Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening.

Authors:  Vincent P Willard; Brian O Diekman; Johannah Sanchez-Adams; Nicolas Christoforou; Kam W Leong; Farshid Guilak
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

5.  Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage.

Authors:  Heather Stanton; Suzanne B Golub; Fraser M Rogerson; Karena Last; Christopher B Little; Amanda J Fosang
Journal:  Nat Protoc       Date:  2011-03-03       Impact factor: 13.491

6.  Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.

Authors:  T G Morgan; A D Rowan; S C Dickinson; D Jones; A P Hollander; D Deehan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

7.  Bovine lactoferricin induces TIMP-3 via the ERK1/2-Sp1 axis in human articular chondrocytes.

Authors:  Dongyao Yan; Di Chen; John R Hawse; Andre J van Wijnen; Hee-Jeong Im
Journal:  Gene       Date:  2013-01-11       Impact factor: 3.688

8.  Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.

Authors:  Linda Troeberg; Kazunari Fushimi; Rama Khokha; Hervé Emonard; Peter Ghosh; Hideaki Nagase
Journal:  FASEB J       Date:  2008-07-16       Impact factor: 5.191

9.  IGF-1 does not moderate the time-dependent transcriptional patterns of key homeostatic genes induced by sustained compression of bovine cartilage.

Authors:  C A Wheeler; S R Jafarzadeh; D M Rocke; A J Grodzinsky
Journal:  Osteoarthritis Cartilage       Date:  2009-02-15       Impact factor: 6.576

10.  Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity in vitro.

Authors:  Henning Voigt; Angelika K Lemke; Rolf Mentlein; Michael Schünke; Bodo Kurz
Journal:  Arthritis Res Ther       Date:  2009-09-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.